Stifel resumed coverage of Orthofix (OFIX) with a Buy rating and $22 price target The firm believes “profitable growth at an attractive valuation” makes it easier to own the shares as investors await long-term ET tailwinds benefiting 7D FLASH, the analyst says while resuming coverage of the spine industry.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OFIX: